Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.83
0.02 (0.29%)
At close: Aug 19, 2025, 3:59 PM
6.81
-0.29%
After-hours: Aug 19, 2025, 05:27 PM EDT
Day One Biopharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 33.91M | 30.76M | 29.21M | 93.76M | 8.19M | n/a | 560K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.77M | 2.88M | 2.98M | 1.59M | 707K | 116K | 280K | 99K | 92K | 89K | 180K | 165K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 30.14M | 27.88M | 26.23M | 92.17M | 7.49M | -116K | 280K | -99K | -92K | -89K | -180K | -165K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -34.97M | -41.07M | -65.33M | 29.64M | -114.81M | -66.77M | -59.52M | -51.44M | -49.25M | -45.85M | -42.74M | -39.7M | -36.72M | -27.75M | -121.93M | -19.24M | -15.44M | -16.09M |
Interest Income | 4.67M | 5.09M | 6.05M | 5.32M | 3.96M | n/a | n/a | 5.29M | 3.41M | n/a | 2.66M | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -30.32M | -36M | -59.24M | 36.16M | -2.85M | -62.41M | -54.51M | -46.15M | -45.86M | -42.39M | -40.11M | -37.8M | -36.53M | -27.75M | -119.83M | -19.24M | -15.47M | -16.1M |
Net Income | -30.32M | -36M | -65.71M | 37.04M | -4.41M | -62.41M | -54.51M | -46.15M | -45.86M | -35.38M | -34.81M | -34M | -36.53M | -27.74M | -119.83M | -19.24M | -14.28M | -15.18M |
Selling & General & Admin | 28.97M | 29.32M | 29.73M | 28.97M | 30.19M | 26.44M | 22.17M | 18.27M | 17.07M | 18.03M | 16.72M | 17.66M | 14.16M | 12.74M | 29.16M | 9.39M | 5.53M | 3.45M |
Research & Development | 36.15M | 39.62M | 61.82M | 33.56M | 92.11M | 40.21M | 37.35M | 33.16M | 32.18M | 27.83M | 26.02M | 22.04M | 22.56M | 15M | 43.58M | 9.85M | 9.91M | 12.63M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -10K | -18K | -3K | -15K | -4K | -26K | 9K | n/a | -1K | 14K | 7K | -27K | -8K |
Operating Expenses | 65.12M | 68.94M | 91.56M | 62.53M | 122.29M | 66.65M | 59.52M | 51.44M | 49.25M | 45.85M | 42.74M | 39.7M | 36.72M | 27.75M | 72.74M | 19.24M | 15.44M | 16.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.66M | n/a | n/a | 2K | 4K | 6K | 7K | 7K |
Selling & Marketing Expenses | n/a | n/a | -1.82M | n/a | n/a | -116K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68.88M | 71.83M | 94.54M | 64.13M | 123M | 66.77M | 59.52M | 51.44M | 49.25M | 45.85M | 42.74M | 39.7M | 36.72M | 27.75M | 72.74M | 19.24M | 15.44M | 16.09M |
Income Tax Expense | n/a | n/a | 6.47M | -882K | 1.55M | 72.72K | n/a | -99K | n/a | -7.02M | -5.29M | -3.8M | -189K | -3K | 4K | 7K | -27K | n/a |
Shares Outstanding (Basic) | 103.07M | 102.71M | 93.62M | 96.62M | 87.12M | 86.68M | 87.23M | 85.95M | 74.96M | 71.97M | 73.46M | 71.01M | 60.76M | 58.38M | 61.95M | 61.93M | 61.93M | 61.93M |
Shares Outstanding (Diluted) | 103.07M | 102.71M | 93.62M | 96.94M | 87.12M | 86.68M | 87.23M | 85.95M | 74.96M | 71.97M | 73.46M | 71.01M | 60.76M | 58.38M | 61.95M | 61.93M | 61.93M | 61.93M |
EPS (Basic) | -0.29 | -0.35 | -0.7 | 0.38 | -0.05 | -0.72 | -0.62 | -0.54 | -0.61 | -0.49 | -0.47 | -0.48 | -0.6 | -0.48 | -1.93 | -0.31 | -0.23 | -0.25 |
EPS (Diluted) | -0.29 | -0.35 | -0.7 | 0.38 | -0.05 | -0.72 | -0.62 | -0.54 | -0.61 | -0.49 | -0.47 | -0.48 | -0.6 | -0.48 | -1.93 | -0.31 | -0.23 | -0.25 |
EBITDA | -34.97M | -40.17M | -64.57M | 29.64M | -114.49M | -66.77M | -59.5M | -51.44M | -49.25M | -45.85M | -42.73M | -39.7M | -36.59M | -27.75M | -21.97M | -19.18M | -15.39M | -16.05M |
EBIT | -30.32M | -41.07M | -65.33M | 29.64M | -114.81M | -66.77M | -59.52M | -51.44M | -49.25M | -45.85M | -42.74M | -39.7M | -36.72M | -27.75M | -21.95M | -19.23M | -15.44M | -16.09M |
Depreciation & Amortization | 964K | 894K | 759K | 746K | 408K | 116K | 103K | 99K | 92K | 89K | 180K | 165K | 133K | 53K | 5K | 50K | 49K | 49K |